TIGIT and neoplasm: In hypoxia status, tumor cells inhibited immune cells’ antitumor ability by interacting with inhibitory receptors in immune cells like PDCD1, TIGIT, and LILRB or weakening the immune-stimulation ligand–receptor interactions such as CCL, TNF, and FASLG.